Lv51
1140 积分 2025-04-22 加入
Sequential CD19/CD22 CAR-T cell therapy following ASCT shows improved efficacy versus CAR-T alone in relapsed/refractory large B-cell lymphoma
21天前
已完结
CD19 CAR‑T induces complete and durable remission in cold agglutinin syndrome associated relapse and refractory diffuse large B cell lymphoma
24天前
已完结
Non-ICANS neurological complications after CAR T-cell therapies: recommendations from the EBMT Practice Harmonisation and Guidelines Committee
5个月前
已完结